Combination of model-free and model-based analysis of dynamic contrast enhanced MRI for breast cancer diagnosis

Dynamic contrast enhancement (DCE) is the leading technique in magnetic resonance imaging for cancer detection and diagnosis. However, there are large variations in the reported sensitivity and specificity of this method that result from the wide range of contrast-enhanced MRI sequences and protocols, image processing methods, and interpretation criteria. Analysis methods can be divided to physiological based models that take into account the vascular and tissue specific features that influence tracer perfusion, and to model free algorithms that decompose enhancement patterns in order to segment and classify different tissue types. Inhere we present a general hybrid method for analyzing dynamic contrast enhanced images integrating a mathematical, model-free technique with a model derived approach that characterizes tissue microvasculature function. We demonstrate the application of the method for breast cancer diagnosis. A brief description of this approach was recently presented for the diagnosis of prostate cancer. The model free method employed principal component analysis and yielded eigen-vectors of which two were relevant for characterizing breast malignancy. The physiological relevance of the two eigen-vectors was revealed by a quantitative correlation with the model based three time point technique. Projection maps of the eigen-vector that specifically related to the wash-out rate of the contrast agent depicted with high accuracy breast cancer. Overall, this hybrid method is fast, standardized, and yields parametric images characterizing tissue microvascular function. It can improve breast cancer detection and be potentially extended as a computer-aided tool for the detection and diagnosis of other cancers.

[1]  Tim W. Nattkemper,et al.  An Adaptive Tissue Characterisation Network for Model-Free Visualisation of Dynamic Contrast-Enhanced Magnetic Resonance Image Data , 2005 .

[2]  Erez Eyal,et al.  Model‐based and model‐free parametric analysis of breast dynamic‐contrast‐enhanced MRI , 2009, NMR in biomedicine.

[3]  R. Blanks,et al.  Effect of NHS breast screening programme on mortality from breast cancer in England and Wales, 1990-8: comparison of observed with predicted mortality , 2000, BMJ : British Medical Journal.

[4]  D M Ikeda,et al.  Progress report from the American College of Radiology Breast MR Imaging Lexicon Committee. , 2001, Magnetic resonance imaging clinics of North America.

[5]  S. Taplin,et al.  Breast cancer screening controversies. , 2003, The Journal of the American Board of Family Practice.

[6]  R. J. Alfidi,et al.  Nuclear magnetic resonance imaging of the human breast , 1984 .

[7]  Lorenzo L. Pesce,et al.  Reliable and computationally efficient maximum-likelihood estimation of "proper" binormal ROC curves. , 2007, Academic radiology.

[8]  E. Morris Breast MR imaging lexicon updated. , 2006, Magnetic resonance imaging clinics of North America.

[9]  Edna Furman-Haran,et al.  Parametric analysis of breast MRI. , 2002, Journal of computer assisted tomography.

[10]  Frederick Kelcz,et al.  Clinical testing of high-spatial-resolution parametric contrast-enhanced MR imaging of the breast. , 2002, AJR. American journal of roentgenology.

[11]  Scott Fields,et al.  Mapping pathophysiological features of breast tumors by MRI at high spatial resolution , 1997, Nature Medicine.

[12]  W. Kaiser,et al.  MR imaging of the breast: fast imaging sequences with and without Gd-DTPA. Preliminary observations. , 1989, Radiology.

[13]  Edna Furman-Haran,et al.  Noninvasive magnetic resonance imaging of transport and interstitial fluid pressure in ectopic human lung tumors. , 2006, Cancer research.

[14]  David A Bluemke,et al.  Breast MRI: State of the Art , 2007, Cancer investigation.

[15]  H. Degani,et al.  Response of MCF7 human breast cancer to tamoxifen: evaluation by the three-time-point, contrast-enhanced magnetic resonance imaging method. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

[16]  A. Miller,et al.  Why is breast-cancer mortality declining? , 2003, The Lancet. Oncology.

[17]  F. Kelcz,et al.  Critical role of spatial resolution in dynamic contrast‐enhanced breast MRI , 2001, Journal of magnetic resonance imaging : JMRI.

[18]  W. Moon,et al.  Optimal Clustering of Kinetic Patterns on Malignant Breast Lesions: Comparison between K-means Clustering and Three-time-points Method in Dynamic Contrast-enhanced MRI , 2007, 2007 29th Annual International Conference of the IEEE Engineering in Medicine and Biology Society.

[19]  S. Shapiro,et al.  Breast cancer screening programmes in 22 countries: current policies, administration and guidelines. International Breast Cancer Screening Network (IBSN) and the European Network of Pilot Projects for Breast Cancer Screening. , 1998, International journal of epidemiology.

[20]  Axel Saalbach,et al.  Image fusion for dynamic contrast enhanced magnetic resonance imaging , 2004, Biomedical engineering online.

[21]  C. Kuhl The current status of breast MR imaging. Part I. Choice of technique, image interpretation, diagnostic accuracy, and transfer to clinical practice. , 2007, Radiology.

[22]  S. Yoo,et al.  Independent Component Analysis for the Examination of Dynamic Contrast-Enhanced Breast Magnetic Resonance Imaging Data: Preliminary Study , 2002, Investigative radiology.

[23]  Elizabeth A Morris,et al.  Diagnostic breast MR imaging: current status and future directions. , 2010, Magnetic resonance imaging clinics of North America.

[24]  B K Rutt,et al.  Temporal sampling requirements for the tracer kinetics modeling of breast disease. , 1998, Magnetic resonance imaging.